Northwestern Mutual Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
AAP
SWP
CFD
FIA
Northwestern Mutual Wealth Management's GNOM Position: Q2 2026 in Review
Northwestern Mutual Wealth Management increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 2.9% in Q2 2026, buying an estimated $191 and bringing the position to 141 shares worth $8.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3203.
Northwestern Mutual Wealth Management first reported a position in GNOM in Q2 2022 and has held it in 17 quarters since. The position peaked at $92M in Q1 2023. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.
- Northwestern Mutual Wealth Management held 141 shares of Global X Genomics & Biotechnology ETF worth $8.01K as of Q2 2026.
- Northwestern Mutual Wealth Management bought 4 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $191.
- Global X Genomics & Biotechnology ETF made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3203 holding.
- Northwestern Mutual Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q2 2022 and has held it in 17 quarters since.
- Northwestern Mutual Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $92M in Q1 2023.
- 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.